Double Osteotomy for Deformity Correction in Pyle Disease

Sponsor
Hawler Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05046977
Collaborator
(none)
5
1
2
12.3
0.4

Study Details

Study Description

Brief Summary

Leg deformity is one of the features of Pyle disease( metaphyseal dysplasia). Correction of valgus deformity of the leg can be done after deformity analysis by double osteotomy so this study showed how double osteotomy can lead to better results than single osteotomy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Single osteotomy
  • Procedure: Double Osteotomy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
5 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Double Osteotomy for Deformity Correction In Pyle Disease: Comparative Study
Anticipated Study Start Date :
Sep 20, 2021
Anticipated Primary Completion Date :
Sep 20, 2022
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Single tibial osteotomy

Single tibial osteotomy done to achieve correction

Procedure: Single osteotomy
Single tibial osteotomy

Active Comparator: Double tibial osteotomy

Double tibial osteotomy done to achieve correction

Procedure: Double Osteotomy
Double Tibial Osteotomy

Outcome Measures

Primary Outcome Measures

  1. Mechanical axis of lower limbs [This mechanical axes were assessed one year after surgery]

    This will determine how much the mechanical axes of the lower limbs were diverted from the normal values. We asked for lower limb radiograph in both Anteroposterior and lateral views and we measure the mechanical axes of the whole lower limb and that of tibial and measures how much the proximal medial tibial angle and compared with normal values

  2. Knee injury and Osteoarthritis outcome score [This score was assessed one year post-operatively]

    This score involves six sections from zero score to 100. The more score is better outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pyle Disease
Exclusion Criteria:
  1. Smoking

  2. Diabets Mellitus

  3. Previous surgery on the limbs

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hawler medical University Erbil Iraq 44001

Sponsors and Collaborators

  • Hawler Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sherwan Ahmed Ali Hamawandi, Assistant professor of orthopedic surgery, Hawler Medical University
ClinicalTrials.gov Identifier:
NCT05046977
Other Study ID Numbers:
  • HMU/Sherwan14
First Posted:
Sep 16, 2021
Last Update Posted:
Sep 16, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sherwan Ahmed Ali Hamawandi, Assistant professor of orthopedic surgery, Hawler Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2021